Cargando…
Systemic therapy for recurrent and/or metastatic head and neck cancer: a population-based healthcare research study in Thuringia, Germany
PURPOSE: Systemic therapy choice for patients with recurrent and/or metastatic head and neck cancer (R/M HNC) is a challenge. Not much is known about systemic therapies used in daily clinical routine and their outcome. METHODS: Data of all 283 patients with R/M HNC (89.4% male, median age: 60 years)...
Autores principales: | Morkramer, Lisa, Geitner, Maren, Boeger, Daniel, Buentzel, Jens, Kaftan, Holger, Mueller, Andreas H., Ernst, Thomas, Guntinas-Lichius, Orlando |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310840/ https://www.ncbi.nlm.nih.gov/pubmed/33517469 http://dx.doi.org/10.1007/s00432-021-03535-4 |
Ejemplares similares
-
Early Mortality among Patients with Head and Neck Cancer Diagnosed in Thuringia, Germany, between 1996 and 2016—A Population-Based Study
por: Kouka, Mussab, et al.
Publicado: (2022) -
Hospitalization for epistaxis: a population-based healthcare research study in Thuringia, Germany
por: Kallenbach, Max, et al.
Publicado: (2020) -
30-day unplanned readmission rate in otolaryngology patients: A population-based study in Thuringia, Germany
por: Rippe, Wido, et al.
Publicado: (2019) -
Role of comorbidity on outcome of head and neck cancer: a population‐based study in Thuringia, Germany
por: Göllnitz, Irene, et al.
Publicado: (2016) -
Gender Disparities in Epidemiology, Treatment, and Outcome for Head and Neck Cancer in Germany: A Population-Based Long-Term Analysis from 1996 to 2016 of the Thuringian Cancer Registry
por: Dittberner, Andreas, et al.
Publicado: (2020)